ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.48 CNY | -1.22% |
|
+2.21% | -9.87% |
| Apr. 28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.7B 374M | Sales 2023 | 2.17B 301M | Capitalization | 11.64B 1.61B |
|---|---|---|---|---|---|
| Net income 2022 | 88M 12.18M | Net income 2023 | -420M -58.14M | EV / Sales 2022 | 4.02 x |
| Net cash position 2022 | 489M 67.69M | Net cash position 2023 | 366M 50.62M | EV / Sales 2023 | 5.19 x |
| P/E ratio 2022 |
140
x | P/E ratio 2023 |
-27.7
x | Employees | 2,612 |
| Yield 2022 |
0.71% | Yield 2023 |
-
| Free-Float | 50.84% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.22% | ||
| 1 week | +2.21% | ||
| Current month | +2.21% | ||
| 1 month | +12.31% | ||
| 3 months | +38.17% | ||
| 6 months | -11.96% | ||
| Current year | -9.87% |
1 week
6.34
6.62
1 month
5.056.62
Current year
3.917.33
1 year
3.9110.11
3 years
3.9111.57
5 years
3.9111.93
10 years
2.9618.60
| Managers | Title | Age | Since |
|---|---|---|---|
Guo Rui Xu
CEO | Chief Executive Officer | 47 | 99-12-31 |
Bing Yao
DFI | Director of Finance/CFO | 42 | 19-11-12 |
Jin Yun Hu
BRD | Director/Board Member | 51 | 99-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Zhong Gong
BRD | Director/Board Member | 58 | 07-06-30 |
Guo Rui Xu
CEO | Chief Executive Officer | 47 | 99-12-31 |
Bing Yao
DFI | Director of Finance/CFO | 42 | 19-11-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +5.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 6.48 | -1.22% | 10,090,300 |
| 24-05-07 | 6.56 | +1.86% | 10,954,410 |
| 24-05-06 | 6.44 | +1.58% | 10,814,900 |
| 24-04-30 | 6.34 | +1.60% | 10,357,410 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotes
ZHEJIANG HISOAR PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the manufacture and sale of pharmaceutical materials and dyes. The Company operates through two segments: Pharmaceutical segment and Dye segment. Pharmaceutical segment manufactures and sells Active Pharmaceutical Ingredients (APIs) and preparations, as well as provides customized production and supporting research and development services for international pharmaceutical companies. The Companyâs pharmaceutical products comprise antibiotic series, hypoglycemic series and cardiovascular series. Dye segment is mainly involved in the manufacture and sale of environmentally friendly reactive dyes, dye intermediates and pigment intermediates. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-20
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.87% | 1.45B | |
| +32.95% | 700B | |
| +26.51% | 569B | |
| -4.97% | 358B | |
| +18.83% | 330B | |
| +3.54% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.70% | 161B |
- Stock Market
- Equities
- 002099 Stock